← Back
$AGIO All transactions

AGIOS PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

23,393

Price

$0

Filed

Jul 10

Insider

Name

Backstrom Jay T.

Title

CIK

0001796398

Roles

Director

Transaction Details

Transaction Date

2025-07-08

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

23,393

Footnotes

This option was granted on July 8, 2025. The shares underlying this option vest as to 25% of the underlying shares on July 8, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter. | Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. | The restricted stock units were granted on July 8, 2025. Beginning on July 8, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

Filing Info

Accession No.

0001439222-25-000080

Form Type

4

Issuer CIK

0001439222

Backstrom Jay T.'s History

Date Ticker Type Value
2025-11-13 LVTX D $0
2025-07-08 AGIO A $0
2025-07-08 AGIO A $0

Other Insiders at AGIO (90d)

Insider Bought Sold Last
Goff Brian
Chief Executive Officer
$662K 2026-04-02
Jones Cecilia
Chief Financial Officer
$109K 2026-04-02
Gheuens Sarah
Chief Medical Officer
$102K 2026-04-02
Burns James William
Chief Legal Officer
$114K 2026-04-02
Milanova Tsveta
Chief Commercial Officer
$113K 2026-04-02
Viswanadhan Krishnan
Chief Corp Dev & Strategy
$103K 2026-04-02